Table 1.

Demographic and clinical characteristics of SLE patients

Characteristic	SLE patients (n = 43)
Age (years; mean [range])	35.0 (21 to 56)
Sex (n; males/females)	2/41
Disease duration (years; mean [range])	8.5 (0.1 to 18)
SLEDAI (mean ± SD)	3.72 ± 3.84
Active (n = 9)a	9.55 ± 4.50
Inactive (n = 34)	2.17 ± 1.42
Cutaneous manifestation (n [%])	26 (60.5)
Arthritis (n [%])	27 (62.8)
Renal manifestation (n [%])	9 (20.9)
Cytopenia (n [%])	11 (25.6)
Serositis (n [%])	8 (18.6)
Prednisolone (n [%]; mean dosage [mg/day])	41 (95.3); 13.0
Hydroxychloroquine (n [%])	34 (79.1)
Azathioprine (n [%])	4 (9.3)
Cyclosporin (n [%])	1 (2.3)
Mizoribine (n [%])	4 (9.3)
Mycophenolate mofetil (n [%])	3 (7.0)

^aSystemic Lupus Erythematosus Disease Activity Index above 4. SD, standard deviation; SLE, systemic lupus erythematosus.